BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16310595)

  • 1. Dystonia and multiple sclerosis.
    Anlar B
    Brain Dev; 2005 Dec; 27(8):602; author reply 602. PubMed ID: 16310595
    [No Abstract]   [Full Text] [Related]  

  • 2. Dystonia in a 13-year-old boy with secondary progressive multiple sclerosis.
    Shiraishi K; Higuchi Y; Ozawa K
    Brain Dev; 2004 Dec; 26(8):539-41. PubMed ID: 15533657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonism/dystonia syndrome secondary to multiple sclerosis with anti-basal-ganglia antibodies.
    Delgado S; Baez S; Singer C; Sengun C; Sheremata WA; Papapetropoulos S
    Mov Disord; 2009 Jan; 24(2):309-11. PubMed ID: 18951536
    [No Abstract]   [Full Text] [Related]  

  • 4. Case with both multiple system atrophy and primary progressive multiple sclerosis with discussion of the difficulty in their differential diagnosis.
    Chuang C; Kocen RS; Quinn NP; Daniel SE
    Mov Disord; 2001 Mar; 16(2):355-8. PubMed ID: 11295795
    [No Abstract]   [Full Text] [Related]  

  • 5. Brainstem glioblastoma in a patient with secondary progressive multiple sclerosis.
    Mantero V; Balgera R; Bianchi G; Rossi G; Rigamonti A; Fiumani A; Salmaggi A
    Neurol Sci; 2015 Sep; 36(9):1733-5. PubMed ID: 25990103
    [No Abstract]   [Full Text] [Related]  

  • 6. Within-session practice effect on paced auditory serial addition test in multiple sclerosis.
    Nagels G; D'hooghe MB; Kos D; Engelborghs S; De Deyn PP
    Mult Scler; 2008 Jan; 14(1):106-11. PubMed ID: 17893110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral striatal necrosis, dystonia and multiple mitochondrial DNA deletions: case study and effect of deep brain stimulation.
    Aniello MS; Martino D; Petruzzella V; Eleopra R; Mancuso M; Dell'Aglio R; Cavallo M; Siciliano G; Defazio G
    Mov Disord; 2008 Jan; 23(1):114-8. PubMed ID: 17960792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal neurogenic pulmonary edema in a patient with progressive multiple sclerosis.
    Bramow S; Faber-Rod JC; Jacobsen C; Kutzelnigg A; Patrikios P; Sorensen PS; Lassmann H; Laursen H
    Mult Scler; 2008 Jun; 14(5):711-5. PubMed ID: 18566036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
    Brettschneider J; Jaskowski TD; Tumani H; Abdul S; Husebye D; Seraj H; Hill HR; Fire E; Spector L; Yarden J; Dotan N; Rose JW
    J Neuroimmunol; 2009 Dec; 217(1-2):95-101. PubMed ID: 19879655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria.
    de Seze J; Debouverie M; Waucquier N; Steinmetz G; Pittion S; Zephir H; Fleury M; Blanc F; Vermersch P
    Mult Scler; 2007 Jun; 13(5):622-5. PubMed ID: 17548441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.
    Kremenchutzky M; Rice GP; Baskerville J; Wingerchuk DM; Ebers GC
    Brain; 2006 Mar; 129(Pt 3):584-94. PubMed ID: 16401620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxysmal dystonia and pathological laughter as a first manifestation of multiple sclerosis.
    Aguirregomozcorta M; Ramió-Torrentà L; Gich J; Quiles A; Genís D
    Mult Scler; 2008 Mar; 14(2):262-5. PubMed ID: 17942514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Uhthoff phenomenon: a potential post transplant complication in advanced progressive multiple sclerosis.
    Morris ES; Sharrack B; Dalley CD; Snowden JA
    Bone Marrow Transplant; 2007 Nov; 40(10):1003-4. PubMed ID: 17891188
    [No Abstract]   [Full Text] [Related]  

  • 15. ADC measurements in various patterns of multiple sclerosis lesions.
    Phuttharak W; Galassi W; Laopaiboon V; Laopaiboon M; Hesselink JR
    J Med Assoc Thai; 2006 Feb; 89(2):196-204. PubMed ID: 16579006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained dystonia as the initial presentation of multiple sclerosis.
    Renganathan R; McCarthy A; O'Connor K; Fitzgerald P; Galvin R
    Ir Med J; 2005; 98(7):219-20. PubMed ID: 16185023
    [No Abstract]   [Full Text] [Related]  

  • 17. Mitochondrial disorders.
    Edmond JC
    Int Ophthalmol Clin; 2009; 49(3):27-33. PubMed ID: 19584620
    [No Abstract]   [Full Text] [Related]  

  • 18. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis.
    Di Pauli F; Reindl M; Ehling R; Schautzer F; Gneiss C; Lutterotti A; O'Reilly E; Munger K; Deisenhammer F; Ascherio A; Berger T
    Mult Scler; 2008 Sep; 14(8):1026-30. PubMed ID: 18632775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of paroxysmal autonomic instability with dystonia (PAID) in a patient with traumatic brain injury.
    Wang VY; Manley G
    J Trauma; 2008 Feb; 64(2):500-2. PubMed ID: 18301221
    [No Abstract]   [Full Text] [Related]  

  • 20. MRI lesion loads and disability relationships in MS: more similar than different?
    Wolinsky JS
    Neurology; 2009 Nov; 73(19):1524-5. PubMed ID: 19828867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.